Inogen Inc
INGN· Nasdaq
Released Feb 23, 2023, after the close
10-K filed Feb 24, 2023, 55 days after period end · 0000950170-23-004370
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $73.18M | $63.37M | $73.98M | $78.92M |
| Net Income | -$56.61M | -$22.88M | -$5.12M |
Inogen Inc · CIK 1294133 · Engraved from SEC EDGAR
| -$1.38M |
| EPS Diluted | — | — | -$0.23 | -$0.06 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.